BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33594675)

  • 1. Training of healthcare providers and use of long-acting reversible contraception in low- and middle-income countries: A systematic review.
    Stokholm Baekgaard R; Gjaerevold Damhaugh E; Mrema D; Rasch V; Khan K; Linde DS
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):619-628. PubMed ID: 33594675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
    Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations.
    Bahamondes L; Villarroel C; Frías Guzmán N; Oizerovich S; Velázquez-Ramírez N; Monteiro I
    Hum Reprod Open; 2018; 2018(1):hox030. PubMed ID: 30895242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Rochester LARC Initiative on adolescents' utilization of long-acting reversible contraception.
    Aligne CA; Phelps R; VanScott JL; Korones SA; Greenberg KB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S890.e1-S890.e6. PubMed ID: 31978438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
    Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
    Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
    Farah D; Andrade TRM; Di Bella ZIKJ; Girão MJBC; Fonseca MCM
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):492-501. PubMed ID: 33140990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study.
    Ma R; Cecil E; Bottle A; French R; Saxena S
    PLoS Med; 2020 Sep; 17(9):e1003333. PubMed ID: 32925909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mobile video training for healthcare providers on long-acting reversible contraceptive (LARC) use among adolescents and young women.
    Xiong W; Li C; Liu X; Gui T; Peng P
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):686-692. PubMed ID: 34023522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review.
    Marmett B; Guaranha DDFK; Carvalho AF; Reis JM; Souza CLE; Dalcin TC; Amantéa SL
    J Pediatr Adolesc Gynecol; 2024 Feb; 37(1):11-17. PubMed ID: 37802383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the uptake of long-acting reversible contraception among female sex workers in post-conflict Northern Uganda: a cross-sectional study.
    Ouma S; Tumwesigye NM; Abbo C; Ndejjo R
    Reprod Health; 2022 Feb; 19(1):34. PubMed ID: 35109873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial).
    Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
    BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Views and experiences of long-acting reversible contraception among ethnic minorities in high-income countries: a systematic review of qualitative studies.
    Ahmed S; McLoughlin Dymond A; Correa M; Willcox ML
    BMJ Sex Reprod Health; 2024 Jan; 50(1):53-66. PubMed ID: 37949640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
    Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
    Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.